Culturing cells_main Culturing cells_tablet Culturing cells_phone_landscape Culturing cells_phone
Electrophoresis_main Electrophoresis_tablet Electrophoresis_phone_landscape Electrophoresis_phone
Scientific Research_main Scientific Research_tablet Scientific Research_phone_landscape Scientific Research_phone


Stem cells are discovered from different areas of the human body ever so often. You have probably heard of stem cells being derived from the embryo, cord blood, bone marrow, fat, cornea, skin, just to mention a few. 

Cord Lining Stem Cells are a very valuable resource with established uses now, and for the future - a stunning potential.

Calecim is a forumation of essential proteins created with Advanced Stem Cell Technology. For skin that acts youthful. And look youthful.

Latest Announcements

08 Jan 2013

CellResearch Corporation Pte Ltd ("the Company") is excited to announce that the U.S Patent and Trademark Office (USPTO) has granted method patentclaims for one member of its family of patents. To add to several earlier granted internal patents is U.S. Patent No. 8,287,854: 'Skin equivalents derived from umbilical cord mesenchymal stem/progenitor cells and umbilical cord epithelial stem/progenitor cells'. This gives the Company a significant foothold in the field of stem cell technology. This development significantly boosts the Company's patent portfolio and enhances its developmental strategy. It also affirms CellResearch Corporation's continued efforts in making cord lining stem cells a choice for regenerative therapies and medicine, where the Company continues to be a global leader in the field.

10 Feb 2014

Indian Patent Grant 

The Board of Directors of CellResearch Corporation Pte Ltd (“the Company”) is delighted to announce that on 21st January 2014, the Indian Patent Office granted the Company’s Indian patent No. 258562.

03 March 2014

Strategic Alliance Agreement extends reach into the People’s Republic of China

 

The Board of Directors of CellResearch Corporation Pte Ltd (“CellResearch”) is delighted to announce that its wholly owned subsidiary Cordlabs Asia Pte Ltd (“CAP”) has extended its strategic alliance and co-operation agreement with Cordlife Group Limited (“CGL”) in relation to the provision of human postnatal umbilical cord tissue storage services to certain territories in the People’s Republic of China (the “PRC”). CellResearch will work with CGL and China Cord Blood Corporation (“CCBC”) towards the provision of these services to the territories on an exclusive basis. CCBC, listed on the New York Stock Exchange, is the largest cord blood banking operator in the PRC, and one of the largest in the world.

30 July 2014

European Patent Grant

The Board of Directors of CellResearch Corporation Pte Ltd (“the Company”) is delighted to announce that on 10 July 2014, the European Patent Office granted the Company’s European patent No. 1 789 534.

08 August 2014

We have 18 granted patents to date and expect more to follow. Click here to find out more.

2 July 2012

We welcome Tebu-Bio to our family of distributors. Tebu-Bio will focus on EU markets.

18 March 2010

CellResearch Corporation partners with CordLife, S E Asia's largest cord blood banking group to offer umbilical cord stem cell storage

5 April 2006

New Applications for Cord Lining Stem Cells: Diabetes and Wound Healing. CellResearch Corporation, a Singapore-based biotech company, announced in July 2005 its discovery of a new source of stem cells found in the outer lining membrane of the umbilical cord. Not only does this source of stem cells yield an extremely high number of cells... Read more here.

Read about the wound healing case studies on our Therapy (Case Study) page

5 July 2005

Singapore Biotech Firm Discovers New Source of Stem Cells.  CellResearch Corporation in Singapore and its team of scientists, headed by Chief Scientist, Dr Phan Toan Thang, have recently made a revolutionary discovery: that the outer lining of the umbilical cord is a rich source of stem cells. Read more here.